{"hands_on_practices": [{"introduction": "A key challenge in base editing is managing off-target effects within the editing window itself. While a base editor is targeted to a specific locus by its guide RNA, the deaminase enzyme often acts on any susceptible base within its reach, leading to unintended \"bystander\" mutations alongside the desired edit. This exercise [@problem_id:2715665] challenges you to apply fundamental probability theory to quantify the likelihood of achieving a pure, single-base edit. Mastering this calculation is essential for predicting the composition of editing outcomes and for designing strategies to improve editing precision.", "problem": "A cytosine base editor acts on a protospacer that contains cytosines at positions $\\{4,6,9\\}$ within the canonical editing window of a clustered regularly interspaced short palindromic repeats (CRISPR) single-guide RNA. In contrast to prime editing, which uses a reverse transcriptase to write a templated change, cytosine base editing proceeds by deamination on single-stranded DNA exposed by the CRISPR-associated (Cas) protein, and can generate bystander edits at multiple cytosines within the window. Consider a single editing exposure in a single cell under the following assumptions grounded in standard probabilistic modeling of rare editing events:\n- Each site $i \\in \\{4,6,9\\}$ experiences deamination independently of the other sites in that same exposure.\n- The event of deamination at site $i$ is modeled as a Bernoulli random variable with success probability $p_i$, where $p_4$, $p_6$, and $p_9$ are given parameters that marginalize all upstream kinetics into a per-site probability for that exposure.\n- Conditional on a deamination event at site $i$, the edit is fixed in the genome with probability $1$ (i.e., assume complete uracil glycosylase inhibition and no back-mutation within the outcome window), so that “edited at site $i$” is equivalent to “deaminated at site $i$” for this problem.\n- No other editable cytosines exist in the window beyond $\\{4,6,9\\}$, and off-window or trans effects can be neglected for the purpose of computing the observable genotype at these three positions.\n\nDefine a “single-cell outcome” as the final genotype across positions $\\{4,6,9\\}$ after the exposure, recorded as edited or unedited at each position.\n\nStarting only from basic probability axioms (independence of events, product rule, and complement rule), derive the closed-form expression, in terms of $p_4$, $p_6$, and $p_9$, for the probability that the single-cell outcome contains an edit at position $6$ and no edits at positions $4$ and $9$. Your final answer must be a single analytical expression with no units. Do not simplify to numerical values.", "solution": "The problem statement is first subjected to validation.\n\nStep 1: Extract Givens\n- A cytosine base editor acts on a protospacer.\n- Editable cytosine positions are at sites $i \\in \\{4, 6, 9\\}$.\n- Editing events at each site are independent.\n- The event of deamination at site $i$ is a Bernoulli random variable with success probability $p_i$. The parameters are $p_4$, $p_6$, and $p_9$.\n- The probability of an edit being fixed, conditional on deamination, is $1$.\n- No other editable cytosines exist in the relevant window. Off-target effects are neglected.\n- A \"single-cell outcome\" is the genotype at positions $\\{4, 6, 9\\}$.\n- The task is to derive the probability for the outcome where there is an edit at position $6$ and no edits at positions $4$ and $9$.\n- The derivation must use only basic probability axioms.\n\nStep 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, modeling a common scenario in base editing with simplifying, but explicitly stated, assumptions standard for such theoretical treatments. The model of independent Bernoulli trials for bystander editing is a well-established simplification in the quantitative analysis of genome editing outcomes. The problem is well-posed, providing all necessary parameters ($p_4, p_6, p_9$) and the crucial condition of independence. The language is objective and precise. The problem is self-contained, consistent, and does not violate any fundamental principles of probability theory or molecular biology. It is not ill-posed, trivial, or reliant on pseudoscience.\n\nStep 3: Verdict and Action\nThe problem is deemed valid. A formal solution will be derived.\n\nThe problem requires the calculation of the probability of a specific joint event concerning the outcomes at three distinct genomic sites. Let us define the elementary events. For each site $i \\in \\{4, 6, 9\\}$, we define the event $E_i$ as the occurrence of an edit at that site. The complementary event, $E_i^c$, is the non-occurrence of an edit at site $i$.\n\nThe problem states that the deamination event at site $i$, which leads directly to an edit, is a Bernoulli random variable with a success probability of $p_i$. Therefore, the probability of an edit at site $i$ is given by the probability of this Bernoulli trial being successful:\n$$\nP(E_i) = p_i\n$$\nThis applies to all three sites, so we have:\n$$\nP(E_4) = p_4\n$$\n$$\nP(E_6) = p_6\n$$\n$$\nP(E_9) = p_9\n$$\nWe are required to use the basic axioms of probability. The complement rule states that for any event $A$, the probability of its complement, $A^c$, is $P(A^c) = 1 - P(A)$. Applying this rule, we can find the probability of no edit occurring at each site:\n$$\nP(E_4^c) = 1 - P(E_4) = 1 - p_4\n$$\n$$\nP(E_6^c) = 1 - P(E_6) = 1 - p_6\n$$\n$$\nP(E_9^c) = 1 - P(E_9) = 1 - p_9\n$$\nThe problem asks for the probability of the single-cell outcome that contains an edit at position $6$ AND no edits at positions $4$ and $9$. This corresponds to the intersection of three events: $E_6$, $E_4^c$, and $E_9^c$. We are looking for the probability of the joint event $E_4^c \\cap E_6 \\cap E_9^c$.\n\nA critical piece of information given in the problem is that the editing events at each site are independent. The definition of independent events $A_1, A_2, \\ldots, A_n$ is that the probability of their intersection is the product of their individual probabilities:\n$$\nP(A_1 \\cap A_2 \\cap \\ldots \\cap A_n) = P(A_1) P(A_2) \\cdots P(A_n)\n$$\nSince the events $E_4$, $E_6$, and $E_9$ are mutually independent, their complements $E_4^c$, $E_6^c$, and $E_9^c$ are also mutually independent. Therefore, any combination of these events and their complements is also an independent set of events. Specifically, the events $E_4^c$, $E_6$, and $E_9^c$ are mutually independent.\n\nApplying the product rule for independent events, we can write the probability of the desired joint event as:\n$$\nP(E_4^c \\cap E_6 \\cap E_9^c) = P(E_4^c) \\times P(E_6) \\times P(E_9^c)\n$$\nSubstituting the expressions for the individual probabilities derived earlier, we obtain the final closed-form expression:\n$$\nP(E_4^c \\cap E_6 \\cap E_9^c) = (1 - p_4) \\times p_6 \\times (1 - p_9)\n$$\nThis expression represents the probability, for a single editing exposure in a single cell, of observing the precise genotype of an unedited cytosine at position $4$, an edited cytosine at position $6$, and an unedited cytosine at position $9$. The derivation proceeds directly from the stated axioms of probability as required.", "answer": "$$\n\\boxed{(1 - p_4) p_6 (1 - p_9)}\n$$", "id": "2715665"}, {"introduction": "The choice of gene editing tool is dictated by the specific change required at the molecular level. This practice [@problem_id:2715651] directly compares Base Editors (BEs) and Prime Editors (PEs) by presenting a scenario where a BE is chemically incapable of performing the edit. You will first articulate the fundamental biochemical limitations of BEs and then quantify the practical cost in efficiency when resorting to the more versatile, but mechanistically complex, PE system. This analysis highlights the critical trade-off between an editor's scope of action and its overall performance.", "problem": "A pathogenic variant at a human locus requires changing a single base pair from adenine–thymine to thymine–adenine, i.e., an adenine to thymine transversion on the target strand. You must choose between a Base Editor (BE) approach and a Prime Editing (PE) approach. Using only fundamental bases of molecular biology and chemistry, justify qualitatively why a BE is inadequate for this transversion, and then quantify the marginal cost of using PE in terms of expected efficiency loss relative to a hypothetical transition target at the same locus that would be amenable to BE. Assume independence between elementary steps within each modality.\n\nUse the following mechanistic assumptions and parameterization:\n\n- Fundamental bases to invoke in your reasoning:\n  - Watson–Crick base pairing rules and the Central Dogma (transcription and replication fidelity depend on base pairing).\n  - Chemistry of deamination: cytidine to uridine and adenine to inosine conversions are transitions that alter pairing preferences without reconstructing the purine/pyrimidine scaffold.\n  - Prime editing uses a reverse transcriptase to write an edit templated by a prime editing guide RNA.\n\n- For the hypothetical transition edit performed by a BE (e.g., Adenine Base Editor (ABE) or Cytidine Base Editor (CBE)) at the same locus with a single target base in the window, model the per-allele probability of a correct edit as the product of three independent events:\n  - Target binding and nicking: probability $f_{\\mathrm{bind}}^{\\mathrm{BE}} = 0.80$.\n  - Catalytic deamination of the target base: probability $p_{\\mathrm{deam}} = 0.85$.\n  - Biased repair that resolves the edited base to the desired transition and retains it: probability $p_{\\mathrm{bias}} = 0.80$.\n\n- For the required transversion edit performed by PE (use the PE3 strategy), model the per-allele probability of a correct edit as the product of six independent events:\n  - Target binding by the prime editor complex: probability $f_{\\mathrm{bind}}^{\\mathrm{PE}} = 0.75$.\n  - Successful priming of reverse transcription from the primer binding site: probability $p_{\\mathrm{prime}} = 0.65$.\n  - Reverse transcription extension across the edited segment of length $L = 12$ nucleotides, with per-nucleotide continuation probability $p_{\\mathrm{ext}} = 0.95$.\n  - Favorable flap equilibration to expose the edited flap: probability $p_{\\mathrm{flap}} = 0.70$.\n  - Ligation of the edited flap: probability $p_{\\mathrm{lig}} = 0.90$.\n  - Retention of the edit after nick-directed mismatch repair: probability $p_{\\mathrm{retain}} = 0.80$.\n\nDefine the marginal cost as the expected efficiency loss $\\Delta E \\equiv E_{\\mathrm{BE}} - E_{\\mathrm{PE}}$, where $E_{\\mathrm{BE}}$ is the expected correct-edit fraction for the hypothetical BE-amenable transition at this locus, and $E_{\\mathrm{PE}}$ is the expected correct-edit fraction for the required transversion installed by PE. Compute $\\Delta E$ and report it as a decimal fraction. Round your final result to $3$ significant figures. Do not use a percentage sign.", "solution": "The problem presents two tasks: first, a qualitative justification for the inadequacy of Base Editors (BE) for installing a specific transversion mutation, and second, a quantitative calculation of the efficiency loss incurred by using the more versatile Prime Editing (PE) technology for this task. We shall address these in order.\n\nA proper scientific analysis begins with fundamental principles. The core of the problem lies in the chemical mechanism of action for each gene editing modality. The required edit is the conversion of an adenine–thymine ($A \\cdot T$) base pair to a thymine–adenine ($T \\cdot A$) base pair. On a single strand of DNA, this corresponds to an adenine ($A$) to thymine ($T$) change, which is a transversion, as it involves substituting a purine ($A$) with a pyrimidine ($T$).\n\nBase Editors operate through enzymatic deamination of a target nucleobase. There are two classes of base editors.\n$1$. Cytidine Base Editors (CBEs) use a cytidine deaminase, such as APOBEC$1$, to convert cytidine ($C$) to uridine ($U$). During DNA replication or repair, the cell's machinery treats uridine as thymine ($T$), leading to the ultimate conversion of a $C \\cdot G$ pair to a $T \\cdot A$ pair. This is a transition mutation (pyrimidine-to-pyrimidine).\n$2$. Adenine Base Editors (ABEs) use an engineered adenine deaminase, TadA, to convert adenine ($A$) to inosine ($I$). Inosine is read by cellular polymerases as guanine ($G$), resulting in the conversion of an $A \\cdot T$ pair to a $G \\cdot C$ pair. This is also a transition mutation (purine-to-purine).\n\nThe critical point is that deamination is a hydrolytic reaction that removes an exocyclic amine group from the heterocyclic base. For adenine, this is the amine at the $C6$ position being replaced by a carbonyl group to form inosine. For cytidine, the amine at the $C4$ position is replaced to form uridine. This chemical modification does not, and cannot, alter the fundamental ring structure of the base. It cannot convert a two-ring purine scaffold ($A$ or $G$) into a one-ring pyrimidine scaffold ($C$ or $T$), or vice versa. The required $A \\to T$ edit is a transversion. Because base editors are mechanistically restricted to performing only transition mutations, they are fundamentally inadequate for this task. Their chemistry is incorrect for the desired outcome.\n\nPrime Editors, by contrast, do not rely on modifying an existing base. Instead, they function as a \"search-and-replace\" tool. The PE complex consists of a Cas$9$ nickase fused to a reverse transcriptase. It is guided to the target site by a prime editing guide RNA (pegRNA), which contains not only the guide sequence for targeting but also a reverse transcriptase template encoding the desired edit. The Cas$9$ nicks the target strand, and this nicked strand then serves as a primer for the reverse transcriptase to synthesize a new DNA segment, using the pegRNA as a template. This newly synthesized flap, which contains the edit (in this case, the $A \\to T$ transversion), is then incorporated into the genome through the cell's own DNA repair pathways. Because the edit is written directly from a template, any type of substitution, insertion, or deletion is possible, including transversions.\n\nNow, we proceed to the quantitative analysis. We are asked to compute the marginal cost, defined as the expected efficiency loss $\\Delta E = E_{\\mathrm{BE}} - E_{\\mathrm{PE}}$.\n\nFirst, we calculate the expected efficiency, $E_{\\mathrm{BE}}$, of a hypothetical BE-amenable transition at the same locus. The problem states this is the product of three independent probabilities:\n$E_{\\mathrm{BE}} = f_{\\mathrm{bind}}^{\\mathrm{BE}} \\times p_{\\mathrm{deam}} \\times p_{\\mathrm{bias}}$\nSubstituting the given values:\n$E_{\\mathrm{BE}} = 0.80 \\times 0.85 \\times 0.80$\n$E_{\\mathrm{BE}} = 0.68 \\times 0.80$\n$E_{\\mathrm{BE}} = 0.544$\n\nNext, we calculate the expected efficiency, $E_{\\mathrm{PE}}$, for the required transversion using the PE3 strategy. This process is more complex and is modeled as the product of six independent events:\n$E_{\\mathrm{PE}} = f_{\\mathrm{bind}}^{\\mathrm{PE}} \\times p_{\\mathrm{prime}} \\times p_{\\text{ext}}^L \\times p_{\\mathrm{flap}} \\times p_{\\mathrm{lig}} \\times p_{\\mathrm{retain}}$\nWe are given the parameters: $f_{\\mathrm{bind}}^{\\mathrm{PE}} = 0.75$, $p_{\\mathrm{prime}} = 0.65$, $p_{\\mathrm{ext}} = 0.95$, $L = 12$, $p_{\\mathrm{flap}} = 0.70$, $p_{\\mathrm{lig}} = 0.90$, and $p_{\\mathrm{retain}} = 0.80$.\n\nFirst, we evaluate the probability of successful reverse transcription extension over the entire length $L$:\n$p_{\\text{ext}}^L = (0.95)^{12}$\nThis evaluates to approximately $0.54036$. We shall retain precision for intermediate calculations.\n\nNow, we substitute all values into the expression for $E_{\\mathrm{PE}}$:\n$E_{\\mathrm{PE}} = (0.75) \\times (0.65) \\times (0.95)^{12} \\times (0.70) \\times (0.90) \\times (0.80)$\n$E_{\\mathrm{PE}} \\approx (0.75) \\times (0.65) \\times (0.54036) \\times (0.70) \\times (0.90) \\times (0.80)$\nLet us compute the product sequentially:\n$E_{\\mathrm{PE}} \\approx (0.4875) \\times (0.54036) \\times (0.504)$\n$E_{\\mathrm{PE}} \\approx (0.2634255) \\times (0.504)$\n$E_{\\mathrm{PE}} \\approx 0.132766452$\n\nFinally, we compute the marginal cost $\\Delta E$:\n$\\Delta E = E_{\\mathrm{BE}} - E_{\\mathrm{PE}}$\n$\\Delta E = 0.544 - 0.132766452$\n$\\Delta E \\approx 0.411233548$\n\nThe problem requires the result to be rounded to $3$ significant figures.\n$\\Delta E \\approx 0.411$\n\nThis result quantifies the substantial reduction in efficiency when one must employ the more complex PE machinery for a transversion, compared to the simpler BE machinery used for a hypothetical transition at the same locus. The multi-step nature of prime editing introduces more potential points of failure, leading to a lower overall probability of success.", "answer": "$$\\boxed{0.411}$$", "id": "2715651"}, {"introduction": "Building on our understanding of bystander editing, we can now frame the challenge as a formal engineering optimization problem. There is an inherent conflict in designing a base editor's activity window: a wider window may increase the probability of a successful on-target modification, but it simultaneously elevates the risk of undesired bystander edits. This exercise [@problem_id:2715610] introduces a \"utility function\" to model this trade-off, asking you to use calculus to derive the optimal window width, $w^{\\ast}$, that maximizes the editor's net benefit. This approach demonstrates how to translate complex biological design constraints into a solvable mathematical framework.", "problem": "Base editing modalities fuse a deaminase to a programmable nuclease scaffold from Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). In cytosine and adenine base editors, the deaminase accesses a contiguous editing window of width $w$ (in nucleotides) within which susceptible bases can be modified. A wider window can increase the probability of successful on-target conversion at the intended base because effective exposure scales with accessible positions and dwell time, but it also increases the expected number of bystander conversions among other susceptible bases within the window.\n\nAssume the following modeling choices grounded in first-order reaction statistics and uniform sequence susceptibility:\n- The expected on-target edit yield as a function of window width $w$ is $E_{\\text{on}}(w)=1-\\exp(-\\lambda w)$ with $\\lambda>0$, reflecting a Poisson arrival model where effective hazard grows linearly with $w$ and the probability of at least one successful on-target conversion saturates toward $1$.\n- The expected bystander editing yield is $E_{\\text{by}}(w)=\\rho\\,w$ with $\\rho>0$, reflecting a constant per-nucleotide density of susceptible bystander sites multiplied by an approximately width-independent per-site conversion probability in the regime of interest.\n- A design utility function is defined as $U(w)=\\alpha\\,E_{\\text{on}}(w)-\\beta\\,E_{\\text{by}}(w)$ with $\\alpha>0$ and $\\beta>0$ to weight desired on-target yield against bystander penalties.\n\nImpose the domain constraint $w\\ge 0$. Assume parameters satisfy $\\alpha\\lambda>\\beta\\rho$ so that the optimal window is strictly positive under this model.\n\nUsing only the definitions above and calculus, derive a closed-form analytic expression for the window width $w^{\\ast}$ that maximizes $U(w)$ over $w\\ge 0$. Your final answer should be a single exact expression for $w^{\\ast}$ with no numerical substitution and no units required.", "solution": "The problem statement has been subjected to rigorous validation. All givens are extracted and analyzed.\n\nGivens:\n1.  The expected on-target edit yield function: $E_{\\text{on}}(w)=1-\\exp(-\\lambda w)$, where $w$ is the window width and $\\lambda > 0$.\n2.  The expected bystander editing yield function: $E_{\\text{by}}(w)=\\rho\\,w$, where $\\rho > 0$.\n3.  The design utility function: $U(w)=\\alpha\\,E_{\\text{on}}(w)-\\beta\\,E_{\\text{by}}(w)$, where $\\alpha > 0$ and $\\beta > 0$.\n4.  The domain for the window width: $w \\ge 0$.\n5.  A constraint on the parameters: $\\alpha\\lambda > \\beta\\rho$.\n\nValidation Verdict:\nThe problem is scientifically grounded as a simplified, but plausible, mathematical model of a biophysical process. It is well-posed, providing all necessary definitions and constraints to ensure a unique, meaningful solution exists. The functions are standard for modeling saturation and linear effects, and the utility function is a conventional construct for optimization problems. The constraint $\\alpha\\lambda > \\beta\\rho$ is critical and correctly specified to ensure a non-trivial maximum. The problem is objective, free of ambiguity, and formally structured. It is therefore deemed **valid**. The solution will now proceed.\n\nThe task is to find the window width $w^{\\ast}$ that maximizes the utility function $U(w)$ over the domain $w \\ge 0$. First, we construct the explicit form of the utility function by substituting the given expressions for $E_{\\text{on}}(w)$ and $E_{\\text{by}}(w)$:\n$$\nU(w) = \\alpha(1-\\exp(-\\lambda w)) - \\beta(\\rho w)\n$$\n$$\nU(w) = \\alpha - \\alpha\\exp(-\\lambda w) - \\beta\\rho w\n$$\nTo find the maximum of this function, we employ differential calculus. We must find the critical points by taking the first derivative of $U(w)$ with respect to $w$ and setting it to zero.\nThe first derivative, denoted $U'(w)$, is:\n$$\nU'(w) = \\frac{d}{dw} \\left( \\alpha - \\alpha\\exp(-\\lambda w) - \\beta\\rho w \\right)\n$$\nApplying the rules of differentiation:\n$$\nU'(w) = 0 - \\alpha \\cdot \\exp(-\\lambda w) \\cdot (-\\lambda) - \\beta\\rho\n$$\n$$\nU'(w) = \\alpha\\lambda\\exp(-\\lambda w) - \\beta\\rho\n$$\nWe find the critical point $w^{\\ast}$ by setting the first derivative to zero:\n$$\nU'(w^{\\ast}) = 0 \\implies \\alpha\\lambda\\exp(-\\lambda w^{\\ast}) - \\beta\\rho = 0\n$$\nNow, we solve for $w^{\\ast}$:\n$$\n\\alpha\\lambda\\exp(-\\lambda w^{\\ast}) = \\beta\\rho\n$$\n$$\n\\exp(-\\lambda w^{\\ast}) = \\frac{\\beta\\rho}{\\alpha\\lambda}\n$$\nTo isolate $w^{\\ast}$, we take the natural logarithm of both sides:\n$$\n-\\lambda w^{\\ast} = \\ln\\left(\\frac{\\beta\\rho}{\\alpha\\lambda}\\right)\n$$\n$$\nw^{\\ast} = -\\frac{1}{\\lambda} \\ln\\left(\\frac{\\beta\\rho}{\\alpha\\lambda}\\right)\n$$\nUsing the property of logarithms $\\ln(x^{-1}) = -\\ln(x)$, we can write the expression for $w^{\\ast}$ in a more direct form:\n$$\nw^{\\ast} = \\frac{1}{\\lambda} \\ln\\left(\\left(\\frac{\\beta\\rho}{\\alpha\\lambda}\\right)^{-1}\\right) = \\frac{1}{\\lambda} \\ln\\left(\\frac{\\alpha\\lambda}{\\beta\\rho}\\right)\n$$\nNext, we must verify that this critical point corresponds to a maximum. We use the second derivative test. We compute the second derivative, $U''(w)$:\n$$\nU''(w) = \\frac{d}{dw} \\left( \\alpha\\lambda\\exp(-\\lambda w) - \\beta\\rho \\right)\n$$\n$$\nU''(w) = \\alpha\\lambda \\cdot \\exp(-\\lambda w) \\cdot (-\\lambda) = -\\alpha\\lambda^2\\exp(-\\lambda w)\n$$\nThe parameters $\\alpha$ and $\\lambda$ are given to be positive. Therefore, $\\alpha\\lambda^2$ is positive. The exponential function $\\exp(-\\lambda w)$ is positive for all real $w$. Consequently, the second derivative $U''(w)$ is strictly negative for all $w$:\n$$\nU''(w) = -\\alpha\\lambda^2\\exp(-\\lambda w) < 0\n$$\nA strictly negative second derivative indicates that the function $U(w)$ is strictly concave. Therefore, the unique critical point $w^{\\ast}$ is indeed a global maximum.\n\nFinally, we must check that this solution lies within the specified domain $w \\ge 0$.\nThe expression for $w^{\\ast}$ is $w^{\\ast} = \\frac{1}{\\lambda} \\ln\\left(\\frac{\\alpha\\lambda}{\\beta\\rho}\\right)$.\nSince $\\lambda > 0$, the sign of $w^{\\ast}$ is determined by the sign of $\\ln\\left(\\frac{\\alpha\\lambda}{\\beta\\rho}\\right)$. For $w^{\\ast}$ to be positive, the argument of the natural logarithm must be greater than $1$:\n$$\n\\frac{\\alpha\\lambda}{\\beta\\rho} > 1 \\implies \\alpha\\lambda > \\beta\\rho\n$$\nThis condition is explicitly provided in the problem statement. This guarantees that $w^{\\ast} > 0$, and thus it is a valid physical solution within the domain $w \\ge 0$. The initial slope of the function at $w=0$ is $U'(0) = \\alpha\\lambda - \\beta\\rho > 0$, confirming that utility increases from $w=0$, further supporting that the maximum must occur at $w^{\\ast} > 0$. The derivation is complete.", "answer": "$$\\boxed{\\frac{1}{\\lambda}\\ln\\left(\\frac{\\alpha\\lambda}{\\beta\\rho}\\right)}$$", "id": "2715610"}]}